Group B Strep Correlates of Protection Study
Launched by UNIVERSITY OF WITWATERSRAND, SOUTH AFRICA · May 23, 2024
Trial Information
Current as of February 12, 2025
Completed
Keywords
ClinConnect Summary
Observational Case-Control Study
* A cohort of 15,000 mother-infant dyads will be enrolled at Chris Hani Baragwanath Academic Hospital (n=10,000) and Rahima Moosa Mother and Child Hospital(n=5,000) over an 18-24-month period, anticipated to start in the first quarter of 2019.
* Enrolment into the cohort study will occur at antenatal clinic, during the early stages either of labour or immediately post-delivery.
* In parallel, enrolment of GBS cases will occur at the time of diagnosis of invasive GBS disease. These "retrospective cases" will be enrolled at multiple facilities across South Af...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Pregnant women attending for antenatal care at one of the participating antenatal-clinics and/or delivering at CHBAH or RMMCH.
- • 2. Subjects aged ≥18 years.
- • 3. Able to understand and comply with planned study procedures.
- • 4. Provides written informed consent.
- Exclusion Criteria:
- • 1. Refusal to consent to study participation.
- • 2. Receipt of any blood products in the past 4 weeks or anticipated during labour.
About University Of Witwatersrand, South Africa
The University of Witwatersrand (Wits), located in Johannesburg, South Africa, is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials and research initiatives. With a strong emphasis on interdisciplinary collaboration, Wits leverages its expertise in various medical fields to address critical health challenges in both local and global contexts. The university's clinical trials are designed to generate robust evidence that informs clinical practices and health policies, ultimately contributing to improved patient outcomes. Wits is dedicated to ethical research conduct and fostering partnerships with stakeholders, ensuring that its studies uphold the highest standards of scientific integrity and social responsibility.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Johannesburg, Gauteng, South Africa
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0